Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
422.8 USD | +0.90% | +5.52% | +4.01% |
09:33pm | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
May. 07 | FOMO is Back |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.01% | 108B | |
+11.03% | 104B | |
+1.28% | 22.33B | |
-13.22% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.60% | 17.64B | |
+3.78% | 14.05B | |
+36.73% | 12.51B | |
+295.92% | 8.84B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Vertex Pharmaceuticals : Piper Sandler Adjusts Price Target on Vertex Pharmaceuticals to $323 From $261, Maintains Overweight Rating